公司资料
Veracyte 股价、新闻与催化剂
- 股票代码:
- VCYT
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
42.08 USD (+2.01%)
收盘价
最后更新: 2026年8月17日
3.81B USD
市值
股价为何变动
As of Aug 17, 2026, VCYT closed up 2.01% at $42.08. No new same-company headline was identified in the current news window.
公司概览
业务概览
Veracyte is a diagnostics company focused on genomic testing for cancer and other high-value clinical decisions. Its products help physicians make more informed treatment and biopsy decisions.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Veracyte sits in molecular diagnostics and precision medicine.
商业模式特征
The company depends on test volume, reimbursement, and the expansion of its oncology and pulmonary diagnostics franchises.
生物医药行业定位
Veracyte is a diagnostics platform name whose stock moves more on adoption and reimbursement than on drug-development catalysts.
未来催化剂
- Veracyte's catalysts are Afirma, Decipher, and broader lung and bladder diagnostics adoption. The company improves when recurring testing and reimbursement keep expanding.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。